THE CIGNA GROUP

CI stock represents shares of The Cigna Group, a major U.S. health services company that was formerly known as Cigna Corporation. The ticker CI trades on the New York Stock Exchange. The company provides health insurance and related benefits through its Evernorth and Cigna Healthcare segments, serving customers in the United States and internationally. CI stock gives investors exposure to the managed care and pharmacy benefits management sectors of the healthcare industry.

Recent price performance for CI can be tracked using the live quote and chart on this page, which reflect the latest trading session and short-term movement. Performance over different periods, such as one month, three months, or year to date, depends on market conditions, company results, and sector sentiment. For the most current figures, refer to the performance section displayed alongside the CI quote rather than relying on any fixed snapshot.

Valuation of CI can be assessed with common metrics such as the price-to-earnings ratio, price-to-sales ratio, and price-to-book ratio, along with comparisons to peers in managed care and healthcare services. Enterprise value relative to EBITDA can also be useful. Because these figures change with the stock price and reported financials, investors should check the latest valuation data provided on this page rather than relying on static numbers.

Before trading CI, review the current bid and ask, trading volume, and the day's price range to gauge liquidity and spreads. Consider the company's upcoming earnings dates, dividend schedule, and any recent news that could affect volatility. Also confirm order types, such as market or limit orders, and your position size relative to your plan. The latest CI quote, volume, and corporate event information on this page can help inform those checks.

Analyzing CI's financial performance typically involves reviewing revenue growth, medical cost trends, earnings per share, operating cash flow, and segment results for Evernorth and Cigna Healthcare. Comparing these metrics across quarters and against peers helps reveal trends in profitability and efficiency. CI's official filings and the financial highlights section on this page provide the underlying figures needed for that analysis.

CI faces risks tied to healthcare regulation, changes in medical cost trends, and competitive pressure in insurance and pharmacy benefits management. Customer concentration in large employer or government contracts, litigation, and integration or restructuring challenges can also affect results. Broader market and interest rate movements may influence the stock. These factors mean CI's earnings and share price can react sharply to policy news or unexpected cost developments.